In response to Furst et al, "Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin".
Geller
Wayne
W
Smith
Mark
M
Winter
Helen
H
Brecher
Martin
M
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000097:blood; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000097:blood; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000097:blood; D008133:Long QT Syndrome / Q000139:chemically induced*; D008148:Lovastatin / Q000009:adverse effects* / Q000097:blood; D000069348:Quetiapine Fumarate
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069348:Quetiapine Fumarate; D008148:Lovastatin